Bactiguard Aktie
| 1,47EUR | 0,09EUR | 6,16% |
WKN DE: A115EQ / ISIN: SE0005878741
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 163 | 188 | 199 | 217 | 177 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1,06 | 0,90 | 1,12 | 0,93 | 1,37 |
Bilanz (in Mio. SEK) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 111 | 320 | 308 | 198 | 194 |
| Summe Anlagevermögen | 595 | 560 | 529 | 485 | 476 |
| Summe Aktiva | 707 | 881 | 837 | 683 | 670 |
Bilanz (in Mio. SEK) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 333 | 339 | 342 | 330 | 342 |
| Summe Eigenkapital | 373 | 541 | 496 | 353 | 328 |
| Summe Passiva | 707 | 881 | 837 | 683 | 670 |
Adresse
| Alfred Nobels Allé 150, 146 21 Tullinge | |
| Telefon | +46 (8) 440-58-80 |
| Fax | +46 (8) 440-58-90 |
| Internet | http://www.bactiguard.com |
Management
|
Anders Göransson
Head-Licensing & Executive Vice President |
|
Anna Martling
Independent Director |
|
Carl-Johan Fredin
Chief Licensing Officer |
|
Christine Lind
Chief Executive Officer |
|
Fatima Stensvad Flodin
Chief Quality & Regulatory Officer |
|
Frida Magdalena Persson
Independent Director |
|
Jan Inge Ståhlberg
Independent Director |
|
Kajsa Björklund
Executive Vice President-Research & Development |
|
Mikael Sander
Chief Operating Officer |
|
Nathaniel Bachrach
Head-Research & Development |
|
Nils Peder Christian Kinch
Non-Executive Chairman |
|
Nils Thomas von Koch
Director |
|
Nina Nornholm
Executive Vice President-Communications & IR |
|
Patrick Bach
Chief Financial Officer |
|
Peter Rådqvist
Head-Global Sales |
|
Richard E. Kuntz
Director |
|
Sathish Subramaniam
Chief Technology Officer |